NOTICE: From September 29th, 2025 to October 16, 2025 inclusive, we will be conducting our annual meetings and all-sites Inventory. Therefore orders placed from September 29, 2025 through October 16, 2025 will be accepted, recorded and will be shipped in order received beginning October 17, 2025. It is important that we do this every year. Thank you for your patience and understanding.
James W. Clement, JD, LLM Anti-Aging Research James is a research scientist, attorney, successful serial entrepreneur, CEO and a fervent proponent of life-extension research efforts. James has been present at the leading-edge with anti-aging and regenerative research organizations and boards … Read More
Matthew J. Budoff, MD, FACC, FSCCT, FAHA Cardiology Research, UCLA Cardiology Professor Cardiologist, Dr. Matt Budoff is undeniably the World’s Foremost Expert on Coronary Artery Calcification (CAC) and CT Angiography (CTA). Matt is also a full Professor of Cardiology at … Read More
SNNLive spoke with Gary Mezo, Chairman and CEO of NanoBiotech Pharma, Inc. at Biotech Week 2014 in San Francisco, CA.
NanobacTX killing Nanobacteria (aka CNPs, NPs or Calcifying Nanoparticles) in pure culture. Nanobacteria are responsible for the development of the pathological calcification, inflammation and amyloid soft plaque in Coronary Artery Disease (CAD), Atherosclerosis, kidney stones and tissue calcification.
FOX NEWS REPORT on our research and development of NanobacTX at NanoBiotech Pharma. Nanobacteria is the infectious cause of coronary artery calcification and heart disease. Heart Disease is a treatable infection.